POINT Biopharma Correlations

Summary

PNTDelisted Stock

USD 9.06 0.10 1.09%

The current 90-days correlation between POINT Biopharma Global and Oric Pharmaceuticals is -0.01 (i.e., Good diversification). The correlation of POINT Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

POINT Biopharma Correlation With Market

Average diversification

The correlation between POINT Biopharma Global and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding POINT Biopharma Global and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with POINT Stock

0.63	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.72	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr
0.74	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr

Moving against POINT Stock

0.43	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.4	EC	Ecopetrol SA ADR Sell-off Trend	Pair Corr
0.35	BKRKF	PT Bank Rakyat	Pair Corr
0.35	PPERF	Bank Mandiri Persero	Pair Corr
0.34	JNJ	Johnson Johnson Sell-off Trend	Pair Corr

Related Correlations Analysis

	ORIC	LYRA	INBX	EPIX	CRNX	ALXO	IMTX	BCAB	AVTE	CERE
ORIC		0.47	0.37	0.15	-0.32	0.58	0.5	-0.06	-0.23	-0.07	ORIC
LYRA	0.47		0.44	0.48	-0.23	0.71	0.66	0.27	-0.53	0.17	LYRA
INBX	0.37	0.44		0.33	0.1	0.22	0.38	0.34	-0.17	-0.05	INBX
EPIX	0.15	0.48	0.33		-0.58	0.66	0.79	0.06	-0.92	0.18	EPIX
CRNX	-0.32	-0.23	0.1	-0.58		-0.63	-0.69	0.3	0.73	-0.13	CRNX
ALXO	0.58	0.71	0.22	0.66	-0.63		0.88	-0.17	-0.8	0.1	ALXO
IMTX	0.5	0.66	0.38	0.79	-0.69	0.88		-0.02	-0.85	0.18	IMTX
BCAB	-0.06	0.27	0.34	0.06	0.3	-0.17	-0.02		0.07	0.06	BCAB
AVTE	-0.23	-0.53	-0.17	-0.92	0.73	-0.8	-0.85	0.07		-0.18	AVTE
CERE	-0.07	0.17	-0.05	0.18	-0.13	0.1	0.18	0.06	-0.18		CERE
	ORIC	LYRA	INBX	EPIX	CRNX	ALXO	IMTX	BCAB	AVTE	CERE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IMTX	+ 0.88	ALXO
IMTX	+ 0.79	EPIX
AVTE	+ 0.73	CRNX
ALXO	+ 0.71	LYRA
IMTX	+ 0.66	LYRA
ALXO	+ 0.66	EPIX

High negative correlations

AVTE	- 0.92	EPIX
AVTE	- 0.85	IMTX
AVTE	- 0.8	ALXO
IMTX	- 0.69	CRNX
ALXO	- 0.63	CRNX
CRNX	- 0.58	EPIX

Risk-Adjusted Indicators

There is a big difference between POINT Stock performing well and POINT Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze POINT Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ORIC	2.76	(0.22)	(0.02)	0.01	4.34	(2.49)	5.64	(5.18)	23.18
LYRA	4.22	(0.60)	0.00	(0.31)	0.00	0.00	10.53	(10.00)	41.07
INBX	2.31	0.09	0.02	0.26	2.72	(2.81)	5.54	(6.11)	16.80
EPIX	4.64	(0.64)	0.00	15.31	0.00	0.00	9.30	(6.45)	84.61
CRNX	1.72	(0.02)	(0.01)	0.10	2.47	(1.60)	3.67	(3.45)	16.75
ALXO	3.37	(0.86)	0.00	(0.30)	0.00	0.00	6.94	(7.76)	22.71
IMTX	1.96	(0.46)	0.00	(0.61)	0.00	0.00	3.84	(4.40)	22.12
BCAB	4.44	(0.13)	(0.01)	0.04	4.78	(5.50)	12.86	(7.59)	31.41
AVTE	2.44	0.45	0.18	0.60	2.04	(3.35)	5.58	(3.86)	19.11
CERE	0.77	0.06	(0.05)	0.49	0.94	(1.02)	1.91	(1.59)	6.40

View POINT Biopharma Related Equities

Oric Pharmaceuticals Lyra Therapeutics Inhibrx ESSA Pharma Crinetics Pharmaceuticals Alx Oncology Holdings Immatics NV Bioatla Aerovate Therapeutics Cerevel Therapeutics Holdings RAPT Therapeutics Cyteir Therapeutics Pardes Biosciences Third Harmonic Bio Pmv Pharmaceuticals

Risk & Return

Correlation

POINT Biopharma Corporate Management

MPH MPH	Ex Devel	Profile
FRCSC MD	Chief Director	Profile
Ari Shomair	VP Staff	Profile
Joe McCann	CEO Director	Profile
Donna BA	VP HR	Profile
RPh Herle	Ex Affairs	Profile
BBA FCA	Chief Officer	Profile

Still Interested in POINT Biopharma Global?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC